Emergent BioSolutions Inc. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Emergent BioSolutions Inc. for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Option Exercise | A | 61.01 | 20,321 | 1,239,784 | 20,321 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 58.71 | 812 | 47,673 | 37,713 | 38.5 K to 37.7 K (-2.11 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 57.98 | 409 | 23,714 | 38,525 | 38.9 K to 38.5 K (-1.05 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,081 | 0 | 38,934 | 33.9 K to 38.9 K (+15.01 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Grant | A | 0.00 | 5,081 | 0 | 33,853 | 28.8 K to 33.9 K (+17.66 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Business Opera ... | Payment of Exercise | F | 61.01 | 481 | 29,346 | 28,772 | 29.3 K to 28.8 K (-1.64 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Option Exercise | A | 61.01 | 47,197 | 2,879,489 | 47,197 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Payment of Exercise | F | 58.71 | 1,941 | 113,956 | 111,489 | 113.4 K to 111.5 K (-1.71 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Payment of Exercise | F | 57.98 | 779 | 45,166 | 113,430 | 114.2 K to 113.4 K (-0.68 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Grant | A | 0.00 | 11,801 | 0 | 114,209 | 102.4 K to 114.2 K (+11.52 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Grant | A | 0.00 | 11,801 | 0 | 102,408 | 90.6 K to 102.4 K (+13.02 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Kramer Robert | President and COO | Payment of Exercise | F | 61.01 | 565 | 34,471 | 90,607 | 91.2 K to 90.6 K (-0.62 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Option Exercise | A | 61.01 | 20,321 | 1,239,784 | 20,321 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,081 | 0 | 31,782 | 26.7 K to 31.8 K (+19.03 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Grant | A | 0.00 | 5,081 | 0 | 26,701 | 21.6 K to 26.7 K (+23.50 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | SARAN ATUL | EVP, Corp Dev, GC & ... | Payment of Exercise | F | 61.01 | 534 | 32,579 | 21,620 | 22.2 K to 21.6 K (-2.41 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Option Exercise | A | 61.01 | 13,929 | 849,808 | 13,929 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 58.71 | 540 | 31,703 | 22,425 | 23 K to 22.4 K (-2.35 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 57.98 | 387 | 22,438 | 22,965 | 23.4 K to 23 K (-1.66 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 3,483 | 0 | 23,352 | 19.9 K to 23.4 K (+17.53 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Grant | A | 0.00 | 3,483 | 0 | 19,869 | 16.4 K to 19.9 K (+21.26 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Strei Katherine | EVP, Chief HR Offic ... | Payment of Exercise | F | 61.01 | 448 | 27,332 | 16,386 | 16.8 K to 16.4 K (-2.66 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,722 | 0 | 40,681 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 9,794 | 0 | 50,403 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 61.01 | 36,053 | 2,199,594 | 36,053 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 18,029 | 0 | 60,197 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 6,430 | 0 | 42,168 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 58.71 | 3,826 | 224,624 | 1,479,018 | 1.5 M to 1.5 M (-0.26 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,722 | 0 | 1,482,844 | 1.5 M to 1.5 M (+0.66 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 58.47 | 6,987 | 408,530 | 1,473,122 | 1.5 M to 1.5 M (-0.47 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 57.98 | 2,486 | 144,138 | 1,480,109 | 1.5 M to 1.5 M (-0.17 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 9,794 | 0 | 1,482,595 | 1.5 M to 1.5 M (+0.66 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 58.24 | 10,369 | 603,891 | 1,472,801 | 1.5 M to 1.5 M (-0.70 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 61.01 | 1,566 | 95,542 | 1,483,170 | 1.5 M to 1.5 M (-0.11 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 6,430 | 0 | 1,484,736 | 1.5 M to 1.5 M (+0.43 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 59.65 | 10,369 | 618,511 | 1,478,306 | 1.5 M to 1.5 M (-0.70 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Option Exercise | A | 61.01 | 20,321 | 1,239,784 | 20,321 | |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 5,081 | 0 | 21,696 | 16.6 K to 21.7 K (+30.58 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Grant | A | 0.00 | 5,081 | 0 | 16,615 | 11.5 K to 16.6 K (+44.05 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 58.71 | 5,101 | 299,480 | 157,182 | 162.3 K to 157.2 K (-3.14 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 57.98 | 2,570 | 149,009 | 162,283 | 164.9 K to 162.3 K (-1.56 %) |
| Feb 28 2019 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 61.01 | 1,714 | 104,571 | 164,853 | 166.6 K to 164.9 K (-1.03 %) |